Literature DB >> 15567628

In a randomized controlled trial, missing data led to biased results regarding anxiety.

Lone Ross1, Birthe Lykke Thomsen, Ellen Helle Boesen, Christoffer Johansen.   

Abstract

BACKGROUND AND
OBJECTIVE: Randomization does not protect against bias due to missing observations. In addition, different reasons for missing observations may lead to different invalid results. The purpose of this study was to illustrate how randomized intervention studies can be threatened by bias due to missing observations because of death or nonresponse.
METHODS: A randomized clinical trial of the effect of psychosocial intervention on well-being after an operation for colorectal cancer was conducted in Denmark. Patients were interviewed 3, 6, 12, and 24 months after discharge from hospital.
RESULTS: We found that the probability of nonresponse decreased with increasing anxiety score in the intervention group, but it increased with increasing anxiety score in the control group. This could lead to severe bias in an analysis of the effect of intervention on anxiety. Low physical functioning and low global health status and quality of life were related to an increased probability of dying before the next follow-up, and this association could explain the associations between anxiety and depression, respectively, and the probability of dying observed in crude analyses.
CONCLUSION: Our study emphasizes the importance of performing specific missing data analyses in any study of well-being variables.

Entities:  

Mesh:

Year:  2004        PMID: 15567628     DOI: 10.1016/j.jclinepi.2004.03.010

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  11 in total

1.  Is personality a key predictor of missing study data? An analysis from a randomized controlled trial.

Authors:  Anthony Jerant; Benjamin P Chapman; Paul Duberstein; Peter Franks
Journal:  Ann Fam Med       Date:  2009 Mar-Apr       Impact factor: 5.166

2.  Correspondence of patient word choice with psychologic factors in patients with upper extremity illness.

Authors:  Arjan G J Bot; Ana-Maria Vranceanu; James H Herndon; David C Ring
Journal:  Clin Orthop Relat Res       Date:  2012-06-16       Impact factor: 4.176

3.  Quality of life of Danish colorectal cancer patients with and without a stoma.

Authors:  Lone Ross; Annemette G Abild-Nielsen; Birthe L Thomsen; Randi V Karlsen; Ellen H Boesen; Christoffer Johansen
Journal:  Support Care Cancer       Date:  2006-11-14       Impact factor: 3.603

Review 4.  Causal Inference and Observational Research: The Utility of Twins.

Authors:  Matt McGue; Merete Osler; Kaare Christensen
Journal:  Perspect Psychol Sci       Date:  2010-09

5.  Factors associated with incomplete DASH questionnaires.

Authors:  Arjan G J Bot; Steven Ferree; Valentin Neuhaus; David Ring
Journal:  Hand (N Y)       Date:  2013-03

Review 6.  Lessons to be learned from 25 years of research investigating psychosocial interventions for cancer patients.

Authors:  Anne Moyer; Sarah K Knapp-Oliver; Stephanie J Sohl; Stefan Schnieder; Anna H L Floyd
Journal:  Cancer J       Date:  2009 Sep-Oct       Impact factor: 3.360

7.  Personality and EQ-5D scores among individuals with chronic conditions.

Authors:  Anthony Jerant; Benjamin P Chapman; Peter Franks
Journal:  Qual Life Res       Date:  2008-10-07       Impact factor: 4.147

8.  Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial.

Authors:  Louise Mosborg Aggestrup; Mie Sara Hestbech; Volkert Siersma; Jesper Holst Pedersen; John Brodersen
Journal:  BMJ Open       Date:  2012-03-01       Impact factor: 2.692

9.  Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.

Authors:  Amélie Anota; Guillaume Mouillet; Isabelle Trouilloud; Anne-Claire Dupont-Gossart; Pascal Artru; Thierry Lecomte; Aziz Zaanan; Mélanie Gauthier; Francine Fein; Olivier Dubreuil; Sophie Paget-Bailly; Julien Taieb; Franck Bonnetain
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

10.  Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?

Authors:  Amélie Anota; Zeinab Hamidou; Sophie Paget-Bailly; Benoist Chibaudel; Caroline Bascoul-Mollevi; Pascal Auquier; Virginie Westeel; Frederic Fiteni; Christophe Borg; Franck Bonnetain
Journal:  Qual Life Res       Date:  2013-11-26       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.